NXL vs TGT · rev $301.6K vs P/E 17, rev $51.98B
Nexalin Technology Inc. (NXL) versus Target Corporation (TGT) — a side-by-side from cached financials, not a winner call.
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Michael J. Fiddelke.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
NXL currently screens at market cap $8.5M. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Not investment advice. Open the NXL and TGT stock pages for the full models.
Not investment advice.